RidazololAlternative Names: CAS 413
Latest Information Update: 25 Aug 1995
At a glance
- Originator Aventis
- Class Anti-ischaemics; Antiarrhythmics; Pyridazines; Small molecules
- Mechanism of Action Beta 1 adrenergic receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Arrhythmias; Ischaemic heart disorders